EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid

Koji Hashimoto iD, Yuji Kamijo iD

Life · 11.02.2025 · 15 (2) · 279

DOI: 10.3390/life15020279 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 11.02.2025. Verfasst von Koji Hashimoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto 390-8621, Nagano, Japan. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal dialysis (PD) is a renal replacement therapy that removes solutes, electrolytes, and water via the infusion of dialysis fluid into the peritoneal cavity. However, the non-physiological composition of conventional PD fluids can cause peritoneal injury, leading to complications such as peritoneal fibrosis and encapsulating peritoneal sclerosis. This review highlights recent advancements in PD fluid formulations aimed at improving biocompatibility and reducing peritoneal damage. While glucose-based solutions remain the standard because of their affordability, their glucose degradation products (GDPs) and advanced glycation end-products significantly contribute to peritoneal fibrosis. Innovations, such as neutral pH and low-GDP solutions, have been developed to counter these effects, enhancing peritoneal integrity and preserving residual renal function. Alternative osmotic agents, such as icodextrin, offer superior ultrafiltration. Advancements in buffer formulations, including bicarbonate-based and bicarbonate/lactate combinations, have further enhanced the biocompatibility of PD fluids. Despite these progressions, challenges persist. Therefore, future research should prioritize patient-specific PD solutions to optimize long-term outcomes and minimize adverse effects.

Schlagwörter

Stichwörter der Autor:innen

bicarbonatebiocompatibilityencapsulating peritoneal sclerosisglucose degradation productsicodextrinlactateneutral pH dialysateperitoneal dialysis

Autor:innen und Institutionen

  • Department of Nephrology, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto 390-8621, Nagano, Japan.

ORCID-Profile: Koji Hashimoto, Yuji Kamijo

Zitieren

APA

Hashimoto, K., & Kamijo, Y. (2025). Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid. Life, 15(2), 279. https://doi.org/10.3390/life15020279

Vancouver

Hashimoto K, Kamijo Y. Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid. Life. 2025;15(2):279. doi:10.3390/life15020279

BibTeX
@article{Hashimoto2025,
  author = {Hashimoto, Koji and Kamijo, Yuji},
  title = {Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid},
  journal = {Life},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {279},
  doi = {10.3390/life15020279}
}
Kostenlos starten →